Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
Fish and Richardson
US Department of Justice
Medtronic
Merck

Generated: August 19, 2019

DrugPatentWatch Database Preview

Patent: 9,505,722

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,505,722
Title:Azepane derivatives and methods of treating hepatitis B infections
Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
Inventor(s): Hartman; George D. (Lansdale, PA), Kuduk; Scott (Harleysville, PA)
Assignee: NOVIRA THERAPEUTICS, INC. (Doylestown, PA)
Application Number:14/694,147
Patent Claims:see list of patent claims

Details for Patent 9,505,722

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Hoffman-la Roche PEGASYS peginterferon alfa-2a SYRINGE 103964 002 2002-10-16   Try a Free Trial NOVIRA THERAPEUTICS, INC. (Doylestown, PA) 2034-01-16 RX search
Hoffman-la Roche PEGASYS peginterferon alfa-2a VIAL; SUBCUTANEOUS 103964 001 2002-10-16   Try a Free Trial NOVIRA THERAPEUTICS, INC. (Doylestown, PA) 2034-01-16 RX search
Merck Sharp & Dohme Corp. RECOMBIVAX HB hepatitis b vaccine (recombinant) INJECTION, SUSPENSION 101066 001 1986-07-23   Try a Free Trial NOVIRA THERAPEUTICS, INC. (Doylestown, PA) 2034-01-16 search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,505,722

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2015109130 Jul 23, 2015
United States of America 2015197493 Jul 16, 2015
United States of America 2015197533 Jul 16, 2015
United States of America 2015225355 Aug 13, 2015
United States of America 2016000812 Jan 07, 2016
United States of America 2017015629 Jan 19, 2017
United States of America 2019016682 Jan 17, 2019
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
QuintilesIMS
Mallinckrodt
Cipla
Farmers Insurance
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.